Collaboration Agreement (Details) - Research Collaboration and Co-Development Agreement - item |
1 Months Ended | ||
|---|---|---|---|
Nov. 30, 2022 |
Aug. 06, 2026 |
Jun. 30, 2026 |
|
| Collaboration Agreements | |||
| Maximum number of antibody drug conjugates to be developed | 3 | ||
| Collaboration agreements cost sharing percentage (as a percent) | 50.00% | 50.00% | |
| LigaChem Biosciences | |||
| Collaboration Agreements | |||
| Collaboration agreements cost sharing percentage (as a percent) | 100.00% |